Paper36096885
E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
Chen M and 7 others. Cell Death Dis, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. Papers, record 36096885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36096885
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CDC2-CDC28 Kinases | Major topic |
| Retinal Neoplasms | Major topic |
| Retinoblastoma | Major topic |
| Animals | |
| Cell Cycle Proteins | |
| E2F1 Transcription Factor | |
| Humans | |
| Mice | |
| Mice, Nude | |
| PTEN Phosphohydrolase | |
| Phenotype | |
| Phosphatidylinositol 3-Kinases |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11905807 | Two genetic hits (more or less) to cancer. | Nat Rev Cancer | 2001 | https://conductscience.org/library/papers/11905807 | PubMed |
| 2 | 27189421 | Retinoblastoma. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27189421 | PubMed |
| 3 | 29510820 | The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors. | Dtsch Arztebl Int | 2018 | https://conductscience.org/library/papers/29510820 | PubMed |
| 4 | 24814393 | Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24814393 | PubMed |
| 5 | 22414599 | Retinoblastoma. | Lancet | 2012 | https://conductscience.org/library/papers/22414599 | PubMed |
| 6 | 11293284 | Long-term follow-up of children with retinoblastoma. | Pediatr Hematol Oncol | 2001 | https://conductscience.org/library/papers/11293284 | PubMed |
| 7 | 19066271 | Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. | J Natl Cancer Inst | 2008 | https://conductscience.org/library/papers/19066271 | PubMed |
| 8 | 1531329 | The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. | Genes Dev | 1992 | https://conductscience.org/library/papers/1531329 | PubMed |
| 9 | 7777526 | Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7777526 | PubMed |
| 10 | 7736585 | The retinoblastoma protein and cell cycle control. | Cell | 1995 | https://conductscience.org/library/papers/7736585 | PubMed |
| 11 | 25252974 | Rb suppresses human cone-precursor-derived retinoblastoma tumours. | Nature | 2014 | https://conductscience.org/library/papers/25252974 | PubMed |
| 12 | 23594950 | Molecular mechanisms underlying RB protein function. | Nat Rev Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23594950 | PubMed |
| 13 | 25273089 | RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner. | Cancer Res | 2014 | https://conductscience.org/library/papers/25273089 | PubMed |
| 14 | 26310174 | The Biology of Retinoblastoma. | Prog Mol Biol Transl Sci | 2015 | https://conductscience.org/library/papers/26310174 | PubMed |
| 15 | 18211953 | Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. | Hum Mol Genet | 2008 | https://conductscience.org/library/papers/18211953 | PubMed |
| 16 | 10647931 | The hallmarks of cancer. | Cell | 2000 | https://conductscience.org/library/papers/10647931 | PubMed |
| 17 | 24509483 | RB1 gene inactivation by chromothripsis in human retinoblastoma. | Oncotarget | 2014 | https://conductscience.org/library/papers/24509483 | PubMed |
| 18 | 23498719 | Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. | Lancet Oncol | 2013 | https://conductscience.org/library/papers/23498719 | PubMed |
| 19 | 26288838 | Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26288838 | PubMed |
| 20 | 21252083 | Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China. | Br J Ophthalmol | 2011 | https://conductscience.org/library/papers/21252083 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41473356 | Liposomal AZD5363 Displays Antiproliferation Activities and Induces Apoptosis on Y79 Retinoblastoma Cancer Cells. | South Asian J Cancer | 2025 | https://conductscience.org/library/papers/41473356 | PubMed |
| 41165830 | m6A-mediated upregulation of miR-3690 drives HNSCC progression by regulating nuclear-cytoplasmic signaling pathway. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/41165830 | PubMed |
| 41024209 | Exploration of propionate metabolism-related genes to predict prognosis and immunotherapy response in ovarian cancer. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/41024209 | PubMed |
| 40950663 | Facilitation of natural killer T-cell cytotoxic activity in uterine sarcoma via the CKS2-PI3K-AKT-MICA axis. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40950663 | PubMed |
| 40676553 | DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40676553 | PubMed |
| 40555979 | A novel mesothelioma molecular classification based on malignant cell differentiation. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40555979 | PubMed |
| 40499938 | Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles. | BMJ Open Ophthalmol | 2025 | https://conductscience.org/library/papers/40499938 | PubMed |
| 40070576 | Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40070576 | PubMed |
| 39188686 | Biological functions and therapeutic potential of CKS2 in human cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39188686 | PubMed |
| 38924847 | Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38924847 | PubMed |
| 38920989 | Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38920989 | PubMed |
| 38151291 | Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis. | Cancer Genomics Proteomics | 2024 | https://conductscience.org/library/papers/38151291 | PubMed |
| 37965463 | PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/37965463 | PubMed |
| 37859732 | Identification of CKS2 as a novel prognostic biomarker and potential therapeutic target for oral squamous cell carcinoma. | Transl Cancer Res | 2023 | https://conductscience.org/library/papers/37859732 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36096885
GET https://conductscience.org/api/papers/v1/36096885/references?page=2